 discovery Warburg effect early twentieth century followed development fluorinated glucose analogue (18)F-fluorodeoxyglucose ((18)F-FDG) invention positron emission tomographs laid foundation clinical PET/CT. review discusses challenges obstacles clinical adoption technique. discuss advances instrumentation, including critically important introduction PET/CT current PET/CT protocols. Moreover, provide evidence clinical utility PET/CT patient management potential impact patient outcome, address cost cost-effectiveness. Although review largely focuses (18)F-FDG imaging, also discuss variety additional molecular imaging approaches used cancer phenotyping PET. Throughout review emphasize critical contributions CT strength PET/CT.